MELEMA PHARMA GMBH has a total of 11 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Ukraine and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are CYTAVIS BIOPHARMA GMBH, THERAPIX BIOSCIENCES LTD and LIPOTEK PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Ukraine | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Lentzen Hans | 11 |
#2 | Witthohn Klaus | 7 |
Publication | Filing date | Title |
---|---|---|
EP3205348A1 | Medicine containing recombinant mistellectins for treating brain tumours | |
UA116762C2 | Recombinant mistletoe lectin and use thereof as an adjuvant |